BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology
by on Friday, August 10th, 2012 | No Comments
Conditions: Hodgkin Lymphoma; Metastatic Breast Cancer.
Intervention:
Sponsors: Rennes University Hospital; Rennes University Hospital; Roche Pharma AG; ANR
Recruiting – verified August 2012
Here is the original post: BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology